Next Article in Journal
Effectiveness of Immunotherapy in Non-Small Cell Lung Cancer Patients with a Diagnosis of COPD: Is This a Hidden Prognosticator for Survival and a Risk Factor for Immune-Related Adverse Events?
Previous Article in Journal
Intracranial Efficacy of Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel in Real-World Patients with Non-Small-Cell Lung Cancer and EGFR or ALK Alterations
Previous Article in Special Issue
Evaluation of the Clinical Utility of Genomic Profiling to Inform Selection of Clinical Trial Therapy in Salivary Gland Cancer
 
 
Article

Article Versions Notes

Cancers 2024, 16(7), 1250; https://doi.org/10.3390/cancers16071250
Action Date Notes Link
article pdf uploaded. 22 March 2024 15:45 CET Version of Record https://www.mdpi.com/2072-6694/16/7/1250/pdf-vor
article xml file uploaded 25 March 2024 11:29 CET Original file -
article xml uploaded. 25 March 2024 11:29 CET Update https://www.mdpi.com/2072-6694/16/7/1250/xml
article pdf uploaded. 25 March 2024 11:29 CET Updated version of record https://www.mdpi.com/2072-6694/16/7/1250/pdf
article html file updated 25 March 2024 11:31 CET Original file https://www.mdpi.com/2072-6694/16/7/1250/html
Back to TopTop